Company Chinook Tyee Industry Ltd Toronto S.E.
Equities
GBI.H
CA16961T2083
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 12-12-13 |
Director/Board Member | 72 | 18-12-04 | |
Investor Relations Contact | - | 18-12-31 | |
Franziska Maisch
SAM | Sales & Marketing | - | - |
Stefan Blodgett
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 43 | 21-11-02 | |
Robert Schenk
SAM | Sales & Marketing | - | 21-04-06 |
Marc Wälken
SAM | Sales & Marketing | - | 20-09-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 12-12-13 |
Director/Board Member | 72 | 18-12-04 | |
Frank Otto
BRD | Director/Board Member | - | 22-05-10 |
Oliver Schindler
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,236,039 | 35,004,904 ( 74.11 %) | 0 | 74.11 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+43.31% | 6.29B | |
-16.99% | 4.42B | |
+6.39% | 3.3B | |
-13.10% | 3.05B | |
-4.17% | 2.47B | |
+45.47% | 1.94B | |
-9.11% | 1.66B | |
-2.09% | 1.61B | |
-12.50% | 1.54B |